Andere talen Morinaga Milk Industry Co., Ltd.

Aandelen

2264

JP3926800008

Vertraagde tijd Japan Exchange Andere beurzen 08:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3.105 ^JPY	+0,58%		+1,60%	+13,82%

2023	Morinaga Milk Industry Co., Ltd.'s probiotische Bifidobacterium B-3 ontvangt goedkeuring van individueel erkende registratie in Zuid-Korea	CI
2023	Morinaga Milk Industry Co, Ltd. Herziet de winstverwachting voor de eerste zes maanden eindigend op 30 september 2023 en voor het boekjaar eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hundreds in northeast Japan get sick after drinking school lunch milk	26/04
Morinaga Milk Industry Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/02
Morinaga Milk Industry Relocates Headquarters to a Newer Building in Minato-ku, Tokyo	18/01
Morinaga Milk Industry Co., Ltd. Announces Change of Address	18/01
Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea	17/11
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium B-3 Receives Approval of Individual Recognized Registration in South Korea	17/11
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	01/11
Morinaga Milk Industry Co., Ltd.'s Equity Buyback announced on May 15, 2023, has closed with 1,856,400 shares, representing 4.14% for ¥9,999.53 million.	31-10-23
Morinaga Milk Industry Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	26-10-23
Morinaga Milk Industry Co., Ltd. Revises Earnings Guidance for the First Six Months Ended September 30, 2023 and for the Fiscal Year Ending March 31, 2024	26-10-23
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	02-10-23
Morinaga Milk recibe la aprobación de la ANVISA en Brasil, incluyendo la declaración de funcionalidad para la salud intestinal, para el probiótico bifidobacterium longum, subespecie longum BB536	08-09-23
Das Probiotikum Bifidobacterium longum subsp. longum BB536 von Morinaga Milk erhält die ANVISA-Zulassung mit dem Vermerk „Darmgesundheit“ in Brasilien	08-09-23
Morinaga Milk's Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	07-09-23
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium Longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	07-09-23
Morinaga Milk Industry Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2024	09-08-23
Morinaga Milk Industry Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	09-08-23
Morinaga Milk Industry Issues Restricted Stock Compensation	02-08-23
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	03-07-23
Morinaga Milk Industry Co., Ltd. completed the acquisition of 20% stake in Morinaga Le May Vietnam Joint Stock Company from Le Van May and Do Thanh Tuan.	31-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Morinaga Milk Industry Co., Ltd.

Aandelen

2264

JP3926800008

Andere talen

Filters